iSpecimen Inc (ISPC)
0.28
0.00 (0.00%)
USD |
NASDAQ |
May 07, 11:04
iSpecimen Enterprise Value: -2.496M for May 6, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 06, 2024 | -2.496M |
May 03, 2024 | -2.616M |
May 02, 2024 | -2.584M |
May 01, 2024 | -2.561M |
April 30, 2024 | -2.361M |
April 29, 2024 | -2.288M |
April 26, 2024 | -2.588M |
April 25, 2024 | -2.459M |
April 24, 2024 | -2.481M |
April 23, 2024 | -2.324M |
April 22, 2024 | -1.916M |
April 19, 2024 | -2.386M |
April 18, 2024 | -1.180M |
April 17, 2024 | -3.07M |
April 16, 2024 | -3.078M |
April 15, 2024 | -3.088M |
April 12, 2024 | -2.943M |
April 11, 2024 | -2.943M |
April 10, 2024 | -3.037M |
April 09, 2024 | -3.092M |
April 08, 2024 | -3.096M |
April 05, 2024 | -3.097M |
April 04, 2024 | -3.034M |
April 03, 2024 | -2.996M |
April 02, 2024 | -2.806M |
Date | Value |
---|---|
April 01, 2024 | -2.761M |
March 28, 2024 | -2.897M |
March 27, 2024 | -2.725M |
March 26, 2024 | -2.856M |
March 25, 2024 | -2.722M |
March 22, 2024 | -2.842M |
March 21, 2024 | -2.506M |
March 20, 2024 | -2.280M |
March 19, 2024 | -2.098M |
March 18, 2024 | -2.007M |
March 15, 2024 | -1.670M |
March 14, 2024 | -1.735M |
March 13, 2024 | -0.8253M |
March 12, 2024 | -1.280M |
March 11, 2024 | -1.280M |
March 08, 2024 | -1.283M |
March 07, 2024 | -1.053M |
March 06, 2024 | -0.7376M |
March 05, 2024 | -0.6049M |
March 04, 2024 | -0.7548M |
March 01, 2024 | -0.8363M |
February 29, 2024 | -0.9181M |
February 28, 2024 | -0.9544M |
February 27, 2024 | -1.012M |
February 26, 2024 | -0.8272M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-6.853M
Minimum
Sep 21 2022
135.88M
Maximum
Nov 29 2021
10.62M
Average
0.3114M
Median
Feb 02 2023
Enterprise Value Benchmarks
RadNet Inc | 4.501B |
DermTech Inc | -33.93M |
23andMe Holding Co | -7.431M |
Sera Prognostics Inc | 272.58M |
Progyny Inc | 2.755B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -3.073M |
Revenue (Quarterly) | 2.575M |
Total Expenses (Quarterly) | 5.446M |
EPS Diluted (Quarterly) | -0.34 |
Gross Profit Margin (Quarterly) | 44.58% |
Profit Margin (Quarterly) | -119.3% |
Earnings Yield | -439.3% |
Normalized Earnings Yield | -439.29 |